Pharma Mirror
JANUARY 30, 2022
This type of therapy is often offered by a licensed physical therapist who specializes specifically in young children and babies. It aims at improving a child’s mobility after an injury or illness. You can get these services at home, a daycare center, school, or an outpatient clinic. Typically, the treatment should be provided in a setting that the child feels comfortable.
JAMA Internal Medicine
JANUARY 30, 2022
This randomized clinical trial assesses how the instructions and results of at-home COVID-19 self-tests are interpreted and whether users appropriately quarantine per federal recommendations.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Mirror
JANUARY 30, 2022
Ben Beckley, Global Lead at EmerGENE explores the market challenges holding back Cell and Gene Therapy (C>) from taking its place as an established treatment area. He explains how we can navigate obstacles to ensure C> can achieve its full potential. As a treatment area, C> has shown robust growth in recent years. Some 3,366 treatments are currently in preclinical and clinical development[1].
pharmaphorum
JANUARY 30, 2022
2021 was a record year for investments in UK biotech companies, consolidating the country’s position as one of Europe’s top life science hubs and apparently shrugging off the effects of the pandemic and Brexit. All told, the sector raised £4.5 billion ($6 billion) in public and private financings during the year, almost two-third (60%) up on the previous year, with £1.3 billion coming from initial public offerings (IPOs) on both sides of the Atlantic.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Scienmag
JANUARY 30, 2022
AUGUSTA, Ga. (Jan. 31, 2022) – The search to better understand the tremendous range of responses to infection with the COVID-19 virus — from symptom free to critically ill — has uncovered in some of the sickest patients a handful of rare structural gene variants involved in body processes, like inflammation, which the virus needs to […].
Drug Patent Watch
JANUARY 30, 2022
Fesoterodine fumarate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Aurobindo Pharma Ltd, Dr Reddys Labs Ltd, Zydus Pharms, and Pfizer and, and is included…. The post New tentative approval for Amneal Pharms drug fesoterodine fumarate appeared first on DrugPatentWatch - Make Better Decisions.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
pharmaphorum
JANUARY 30, 2022
The FDA has approved Roche’s much-anticipated faricimab for two major causes of blindness, setting up a market clash with Bayer and Regeneron’s market leading drug Eylea. The US regulator has given the green light to the bispecific antibody – now called Vabysmo – for both neovascular or ‘wet’ age-related macular degeneration (AMD) and diabetic macular oedema (DME).
Scienmag
JANUARY 30, 2022
New research suggests that people may not always want help with sticking to their New Year’s resolutions. Individuals often make resolutions in January to maintain healthy lifestyle regimes – for example to eat better or exercise more often – then fail to keep them. Behavioural scientists frequently interpret such behaviour as evidence of a conflict […].
BioTech 365
JANUARY 30, 2022
Juvenescence Ltd. Portfolio Company Hails Successful Limb Regeneration in Adult Frogs Juvenescence Ltd. Portfolio Company Hails Successful Limb Regeneration in Adult Frogs Findings are expected to inform portfolio company’s innovative approach to Regenerative Medicine DOUGLAS, Isle of Man–(BUSINESS WIRE)–Morphoceuticals Inc.
Scienmag
JANUARY 30, 2022
CHICAGO (January 30, 2022) — Patients with mitral valve disease who live in disadvantaged communities are more likely to experience complications and are at higher risk for death after surgery than those with higher socioeconomic status (SES), according to research presented at the 58th Annual Meeting of The Society of Thoracic Surgeons. “We collaboratively undertook […].
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
BioTech 365
JANUARY 30, 2022
RELIEF THERAPEUTICS Holding AG / Key word(s): AGMEGM 31-Jan-2022 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement.
Scienmag
JANUARY 30, 2022
Human children are known for their sensitivity to social cues (such as eye-gaze and joint attention) more so than other primates. While most research on joint attention (two people focused on the same object) has focused on children living in Western and North American countries, little is known about how caregiver-child interactions differ across cultural […].
BioTech 365
JANUARY 30, 2022
Madrigal Pharmaceuticals To Announce Topline Results from the Phase 3 MAESTRO-NAFLD-1 Study of Resmetirom on Monday, January 31st Madrigal Pharmaceuticals To Announce Topline Results from the Phase 3 MAESTRO-NAFLD-1 Study of Resmetirom on Monday, January 31st CONSHOHOCKEN, Pa., Jan.
Scienmag
JANUARY 30, 2022
Researchers at the Yale School of Public Health were able to accurately predict outbreaks of COVID-19 in Connecticut municipalities using anonymous location information from mobile devices, according to a new study published in Science Advances. The novel analysis applied in the study could help health officials stem community outbreaks of COVID-19 and allocate testing resources more […].
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Drug Patent Watch
JANUARY 30, 2022
This chart shows the pharmaceutical companies with the most patents in Finland. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Finland? appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
JANUARY 30, 2022
Adults with disabilities have worse outcomes when hospitalized with COVID-19 than patients without disabilities, including longer hospital stays and increased risk of readmission, found new research in CMAJ (Canadian Medical Association Journal) [link] The differences were especially pronounced in people younger than 65 years. “[C]onsideration of disability-related needs has largely been absent from the COVID-19 response, […].
Scienmag
JANUARY 30, 2022
New technology could help reduce malnutrition and improve overall health in long-term care homes by automatically recording and tracking how much food residents consume. The smart system, developed by researchers at the University of Waterloo, the Schlegel-UW Research Institute for Aging and the University Health Network, uses artificial intelligence software to analyze photos of plates of food after […].
Scienmag
JANUARY 30, 2022
During the pandemic men were twice as likely as women to fall victim to online extortionists threatening to publish explicit photos, videos, and information about them. That’s according to a new, first-of-its-kind study published in the peer-reviewed journal Victims & Offenders. Young people, Black and Native American women, and LGBTQ individuals were also at higher […].
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Expert insights. Personalized for you.
130 
Let's personalize your content